Search Results 641-650 of 17370 for peptide combinations
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Liver transplant, weight-loss surgery combination benefits obese patients in long term featured image. Featured News. Liver transplant, weight-loss surgery ...
This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with other ...
... combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically. Participation eligibility. Participant eligibility includes ...
August 30, 2021. Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal ...
The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in combination ...
The purpose of this study is to investigate the antitumor activity of navicixizumab monotherapy or in combination with paclitaxel or irinotecan in patients with ...
January 28, 2026. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause featured. Research. New study links ...
Mayo Clinic team takes quantum leap to win global competition with brain-signal model featured · Mayo Clinic researchers find combination therapy reduces effects ...
New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause featured. Research. New study links combination of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!